Neurological Sciences

, Volume 32, Supplement 1, pp 85–88 | Cite as

Migraine and depression: common pathogenetic and therapeutic ground?

  • F. Moschiano
  • D. D’Amico
  • I. Canavero
  • I. Pan
  • G. Micieli
  • G. Bussone
Migraine and Depression

Abstract

Migraine and depression are recognized as comorbid disorders on the basis of several epidemiological data and on the possibility of shared mechanisms. On the other hand, there is a lack of studies concerning therapeutic strategies in patients with this comorbidity. The aim of this paper is to briefly review the literature about the migraine and depression comorbidity and on the putative common neurobiological mechanisms, as well to discuss the possible therapeutic options in treating patients with both disorders.

Keywords

Migraine Depression Comorbidity Pathogenesis Therapy 

References

  1. 1.
    Baskin SM, Lipchik GL, Smitherman TA (2006) Mood and anxiety disorders in chronic headache. Headache 46(Suppl 3):S76–S87PubMedCrossRefGoogle Scholar
  2. 2.
    Radat F, Swendsen J (2004) Psychiatric comorbidity in migraine: a review. Cephalalgia 25:165–178CrossRefGoogle Scholar
  3. 3.
    Lake AE, Rains JC, Penzien DB et al (2005) Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 45:493–506PubMedCrossRefGoogle Scholar
  4. 4.
    Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333PubMedCrossRefGoogle Scholar
  5. 5.
    Breslau N (1998) Psychiatric comorbidity in migraine. Cephalagia 18(Suppl 22):56–61Google Scholar
  6. 6.
    Baskin SM, Smitherman TA (2009) Migraine and psychiatric disorders: comorbities, mechanisms, and clinical applications. Neurol Sci 30(Suppl 1):S61–S65PubMedCrossRefGoogle Scholar
  7. 7.
    Finocchi C, Villani V, Casucci G (2010) Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci 31(Suppl 1):S95–S98PubMedCrossRefGoogle Scholar
  8. 8.
    Wang SJ, Liu HC, Fuh JL et al (1999) Comorbidity of headaches and depression in the elderly. Pain 82(3):239–243Google Scholar
  9. 9.
    Lipton RB, Hamelsky SW, Kolodner KB et al (2000) Migraine, quality of life, and depression: a population-based case–control study. Neurology 55:629–635PubMedGoogle Scholar
  10. 10.
    Merikangas KR, Angst J, Isler H (1990) Migraine and psychopatology. Results of Zurich cohort study of young adults. Arch Gen Psychiatry 47:849–853PubMedGoogle Scholar
  11. 11.
    Breslau N, Schultz LR, Stewart WF et al (2000) Headache and major depression: is the association specific to migraine? Neurology 54:308–313PubMedGoogle Scholar
  12. 12.
    Swartz KL, Pratt LA, Armenian HK et al (2000) Mental disorders and the incidence of migraine headache in a community sample. Arch Gen Psychiatry 57:945–950PubMedCrossRefGoogle Scholar
  13. 13.
    Patel NV, Bigal ME, Koloner KB et al (2004) Prevalence and impact of migraine and probable migraine in a health plan. Neurology 63:1432–1438PubMedGoogle Scholar
  14. 14.
    Mc Williams LA, Goodwin RD, Cox BJ (2004) Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111:77–83CrossRefGoogle Scholar
  15. 15.
    Fasmer OB, Oedegaard KJ (2001) Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry 2:149–155PubMedCrossRefGoogle Scholar
  16. 16.
    Oedegaard KJ, Angst J, Neckelmann D et al (2005) Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headache Pain 6:378–386PubMedCrossRefGoogle Scholar
  17. 17.
    Oedegaard KJ, Neckelmann D, Mykletun A (2006) Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The Hunt Study. Cephalalgia 26:1–6PubMedCrossRefGoogle Scholar
  18. 18.
    Breslau N, Lipton RB, Stewart WF et al (2003) Comorbidity of migraine and depression. Neurology 60:1308–1312PubMedGoogle Scholar
  19. 19.
    Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 137:11–23CrossRefGoogle Scholar
  20. 20.
    Antonaci F, Nappi G, Galli F et al (2011) Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain [Epub ahead of print]Google Scholar
  21. 21.
    Juhasz G, Zsombok T, Laszik A et al (2003) Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 17:231–240PubMedGoogle Scholar
  22. 22.
    Todt U, Freudenberg J, Goebel I et al (2006) Variation of the serotonin receptor gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67:1707–1709PubMedCrossRefGoogle Scholar
  23. 23.
    Marziniak M, Mossner R, Schmitt A et al (2005) A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 64:157–159PubMedGoogle Scholar
  24. 24.
    Kotani K, Shimomura T, Shimomura F et al (2002) A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 42:893–895PubMedCrossRefGoogle Scholar
  25. 25.
    Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1295–1300CrossRefGoogle Scholar
  26. 26.
    Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180:305–313Google Scholar
  27. 27.
    Lotrich FE, Pollock BG (2004) Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Gen 14:121–129CrossRefGoogle Scholar
  28. 28.
    Caspi A, Sugden K, Moffit TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389PubMedCrossRefGoogle Scholar
  29. 29.
    Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with polymorphisms in the serotonin transporter gene regulatory region. Science 274:1527–1531PubMedCrossRefGoogle Scholar
  30. 30.
    Sen s, Burmeister M, Ghosh D (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127:85–89CrossRefGoogle Scholar
  31. 31.
    Perutka SJ, Price SC, Wilhoit TL et al (1998) Comorbid migraine wth aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NNcoI alleles. Mol Med 4:14–21Google Scholar
  32. 32.
    Seligman MEP (1975) Helplessness: on depression development and death. WH Freeman and Company, San FranciscoGoogle Scholar
  33. 33.
    Lipton RB, Stewart WF, Diamond S et al (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657PubMedCrossRefGoogle Scholar
  34. 34.
    Kessler RC, McGonagle KA, Zhao S (1994) Lifetime and 12-month prevalence of DSM-III R psychiatric disorder in the United States. Results from the National Comorbidity Survey. Arch Gen Psych 51:8–19Google Scholar
  35. 35.
    Peterlin BL, Katsnelson MJ, Calhoun AH (2009) The association between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen. Curr Pain Headache Rep 13(5):404–412PubMedCrossRefGoogle Scholar
  36. 36.
    Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis—part I. Headache 46:3–23PubMedCrossRefGoogle Scholar
  37. 37.
    Scher AI, Midgette LA, Lipton RRB (2008) Risk factors for headache chronification. Headache 48:16–25PubMedCrossRefGoogle Scholar
  38. 38.
    Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46:1334–1343PubMedCrossRefGoogle Scholar
  39. 39.
    Smitherman TA, Penzien DB, Maizels M (2008) Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep 12:224–229PubMedCrossRefGoogle Scholar
  40. 40.
    Monroe SM, Harkness KL (2005) Life stress, the “kindling” hypothesis, and recurrence of depression: consideration from a life stress perspective. Psychol Rev 112:417–445PubMedCrossRefGoogle Scholar
  41. 41.
    Tietjen GE, Brandes JL, Peterlin BL et al (2009) Allodynia in migraine: association with comorbid pain conditions. Hedache 49:1333–1344CrossRefGoogle Scholar
  42. 42.
    Lovati C, D’Amico D, Bertora P (2009) Allodynia in migraine: frequent random association or unavoidable consequence? Expert Rev Neurother 9(3):395–408PubMedCrossRefGoogle Scholar
  43. 43.
    Welch KMA, Nagesh V, Aurora SK et al (2001) Periaquiductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRefGoogle Scholar
  44. 44.
    Videbech P, Ravnkilde B (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957–1966PubMedCrossRefGoogle Scholar
  45. 45.
    Barden N (2004) Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29:185–193PubMedGoogle Scholar
  46. 46.
    Peres MF, Sanchez DR, Seabra ML et al (2001) Hypotalamic involment in chronic migraine. J Neurol Neurosurg Psychiatry 71:747–751PubMedCrossRefGoogle Scholar
  47. 47.
    Bigal ME, Lipton RB, Holland PR et al (2007) Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68:1851–1861PubMedCrossRefGoogle Scholar
  48. 48.
    Miura H, Ozaki N, Sawada M et al (2008) A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11:198–209PubMedCrossRefGoogle Scholar
  49. 49.
    Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 46(suppl 3):S98–S109PubMedCrossRefGoogle Scholar
  50. 50.
    Heckman BD, Holroyd KA, Himawan L et al (2009) Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain 146:56–64PubMedCrossRefGoogle Scholar
  51. 51.
    Smitherman TA, Walters AB, Maizels M et al (2010) The use of antidepressants for headache prophylaxis. CNS Neurosci Ther 1–8Google Scholar
  52. 52.
    Evers S (2008) Treatment of migraine with prophylactic drugs. Expert Opin Pharmacother 9(15):2565–2573PubMedCrossRefGoogle Scholar
  53. 53.
    Colombo B, Annovazzi POL, Comi G (2004) Therapy of primary hedaches: the role of antidepressant. Neurol Sci 25:S171–S175PubMedCrossRefGoogle Scholar
  54. 54.
    Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS, European Federation of Neurological Societies (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16(9):968–981PubMedCrossRefGoogle Scholar
  55. 55.
    Proietti Cecchin A, Mea E, Tullo V et al (2009) Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 30(Suppl 1):S101–S104CrossRefGoogle Scholar
  56. 56.
    Nahas Z, Marangell LB, Husain MM et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • F. Moschiano
    • 1
  • D. D’Amico
    • 2
  • I. Canavero
    • 1
  • I. Pan
    • 1
  • G. Micieli
    • 1
  • G. Bussone
    • 2
  1. 1.National Institute of NeurologyIRCCS C. Mondino FoundationPaviaItaly
  2. 2.Headaches Unit, Neurological Institute “C. Besta” IRCCS FoundationMilanItaly

Personalised recommendations